Abstract
Severely ill influenza patients are at increased risk of invasive pulmonary aspergillosis (IPA). Previous reports suggest that Coronavirus Disease 2019 (COVID-19) patients may also be at increased risk of IPA. Here we present an Aspergillus co-infection in a COVID-19 immunocompetent patient, complicated by bacteremia and persistent hyperthermia. We describe the challenges in diagnosing IPA in COVID-19 immunocompetent patients and how the patient responded to the treatment.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Medical Mycology Case Reports |
Vol/bind | 31 |
Nummer | Special issue |
Sider (fra-til) | 29-31 |
Antal sider | 3 |
ISSN | 2211-7539 |
DOI | |
Status | Udgivet - mar. 2021 |